Oxovanadium(iv) complexes catalysed CO2 cycloaddition resulting up to 100% conversion of epoxides to cyclic carbonates under relatively benign condition. Transformation of oxovanadium(iv) to dioxovanadium(v) in the process of crystallization.
Cr(III) centers have been incorporated into melamine‐terephthalaldehyde porous organic framework (MT‐POF) through N‐donor site coordination. Morphological studies by SEM give evidence of the transformation of spherulitic texture of non‐metalated MT‐POF to aggregated platelike structure in chromium metalated POF, MT‐Cr(III) POF (bulk). The flattening in the surface morphology of bulk MT‐Cr(III) POF might be a consequence of conformational change in POF caused by the template effect of the Cr(III) coordination. On sonication, bulk MT‐Cr(III) POF transformed into a distinguishable stacked nanosheet structure in MT‐Cr(III) POFN as revealed by FE‐SEM and TEM images. MT‐Cr(III) POFN could catalyse the carbon dioxide cycloaddition reaction to epoxides to yield cyclic carbonates in presence of tetrabutylammonium bromide (TBAB) co‐catalyst. It was found that bulkier epoxide substrates showed lesser conversions to their corresponding cyclic carbonates (styrene oxide, 41 %; allyl glycidyl ether, 70 %; butyl glycidyl ether, 63 % conv.), whereas smaller substrates showed much higher conversions (epichlorohydrin, 96 %; epibromohydrin, 95 % conv.) under the reaction conditions [MT‐Cr(III) POFN, 10 mg; TBAB, 2 mol%; 5 bar CO2; 60 °C] giving a clear evidence of the substrate discrimination. The reason for the lesser conversions of the bigger substrates can be attributed to the steric clash rendered by the POF network.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.